#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    T-cell type acute leukaemia Hypersensitivity pneumonitis Partial lipodystrophy Non-Hodgkin's lymphoma refractory Narcolepsy Osteosarcoma metastatic Primary hyperoxaluria Nephrotic syndrome Deafness Pulmonary sarcoidosis Anti-HLA antibody test positive Spinal cord injury Cerebral arteriovenous malformation haemorrhagic Systemic lupus erythematosus Biotinidase deficiency More trials…

    Learn about Rare Diseases

    Angiosarcoma non-metastatic – Trials in Disease Niemann-Pick disease – Life with Disease Noonan syndrome Von Willebrand’s disease – Life with Disease Proteus syndrome – Basic Information Pulmonary sarcoidosis – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency – Life with Disease Retinitis pigmentosa – Life with Disease Idiopathic inflammatory myopathy Encephalitis autoimmune – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abemaciclib Clazakizumab Niraparib Prx005 Cytarabine Vaborbactam Safinamide Sotalol HSP-CAR30 Terbinafine Hydrochloride Annamycin Cd7-Cart01 Adct-402 Gskvx000000009151 Bisoprolol Luspatercept Obefazimod CICLOPIROX Betahistine Dihydrochloride Serine More therapies…

    Learn about Your Condition

    Thromboangiitis obliterans Lung adenocarcinoma stage III Transplant rejection Peritonitis Adrenoleukodystrophy Endocrine disorder Persistent depressive disorder Hyperchylomicronaemia Breast cancer in situ Takayasu's arteritis Dilated cardiomyopathy Anogenital dysplasia Gastrointestinal carcinoma Haemoptysis Postprandial hypoglycaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness of Infliximab for Children with Inflammatory Bowel Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Infliximab
    Italy

  • Study on the Safety and Body Processing of Bimekizumab in Children with Juvenile Idiopathic Arthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Juvenile spondyloarthritis
    • Juvenile idiopathic arthritis
    • Juvenile psoriatic arthritis
    Investigated Drugs:
    • Bimekizumab
    France Germany Poland Spain

  • Study on Atorvastatin’s Effect on Prostate Cancer Progression in Patients Undergoing Androgen Deprivation Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer recurrent
    • Prostate cancer
    Investigated Drugs:
    • Atorvastatin
    Denmark Estonia Finland Norway

  • Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Hydrocortisone Sodium Phosphate
    • Hydrocortisone Sodium Succinate
    • Prednisolone Sodium Succinate
    Belgium Denmark Estonia Finland France Germany +8

  • Study of Clofarabine for Patients with Advanced or Metastatic Bladder Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Transitional cell carcinoma
    Investigated Drugs:
    • Clofarabine
    Austria

  • Study on Clopidogrel and Acetylsalicylic Acid for Patients with Coronary Artery Disease and Non-ST-segment Elevation Acute Coronary Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute coronary syndrome
    • Coronary artery disease
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    The Netherlands
Previous Page
1 … 612 613 614 615 616 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!